Dobixin Injection 2 mg/ml contains Doxorubicin Hydrochloride, a potent anthracycline chemotherapeutic agent used in the treatment of a wide range of cancers. Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, thereby preventing DNA replication and RNA synthesis. This mechanism leads to the death of rapidly dividing cancer cells, making Dobixin a highly effective agent in oncology.

Doxorubicin is widely used both as a single-agent chemotherapy and in combination regimens for various solid tumors and hematologic malignancies. Its effectiveness against cancer, including breast cancer, leukemia, lymphoma, sarcomas, and other neoplasms, has made it a cornerstone in many chemotherapy protocols. Dobixin’s intravenous formulation ensures precise dosing and rapid systemic distribution for optimal therapeutic effect.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Dobixin Injection 2 mg/ml is indicated for the treatment of:

• Breast cancer (adjuvant and metastatic settings)

• Hematologic malignancies: Acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin and non-Hodgkin lymphoma

• Soft tissue and bone sarcomas

• Bladder cancer, ovarian cancer, and other solid tumors as part of combination chemotherapy protocols

• Used in combination therapy to enhance efficacy and improve patient outcomes in multi-agent chemotherapy regimens

Dobixin is indicated for adult patients, and pediatric dosing should be carefully determined based on age, body surface area, and clinical condition.

Dosage and Administration

• Administration: Intravenous infusion only. Dobixin should never be administered intramuscularly or subcutaneously due to the risk of severe tissue necrosis.

• Adult dosage: Typically calculated based on body surface area (mg/m²), administered in cycles depending on the specific cancer type and combination regimen.

• Pediatric dosage: Requires careful calculation based on body surface area and organ function, under strict medical supervision.

• Infusion should be performed slowly, usually over 15–60 minutes, with close monitoring for side effects.

Doxorubicin dosing must be adjusted in patients with renal or hepatic impairment, and cumulative lifetime doses should be tracked due to the risk of cardiotoxicity.

Precautions

• Dobixin is highly cytotoxic and should only be administered by trained healthcare professionals in a controlled clinical setting.

• Monitor cardiac function before and during therapy due to the risk of cardiomyopathy and congestive heart failure.

• Use cautiously in patients with liver or kidney impairment, bone marrow suppression, or active infections.

• May interact with other chemotherapeutic agents, especially those that increase cardiac risk.

• Pregnancy and breastfeeding are contraindicated; the drug is teratogenic and may harm the fetus.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects include:

• Bone marrow suppression: leukopenia, neutropenia, anemia, thrombocytopenia

• Gastrointestinal symptoms: nausea, vomiting, mucositis, diarrhea

• Hair loss (alopecia) and skin changes

• Red discoloration of urine for 1–2 days post-administration (harmless)

Serious but less frequent side effects:

• Cardiotoxicity: arrhythmias, heart failure, cardiomyopathy

• Severe infections due to immunosuppression

• Extravasation at the injection site causing tissue necrosis

Close monitoring of blood counts, liver function, and cardiac function is essential throughout treatment.

Storage

Store at 2–8°C, protect from light, and do not freeze. Keep out of reach of children. Use only under professional supervision.

Dobixin Injection 2 mg/ml is a highly effective chemotherapeutic agent for the treatment of multiple cancers. Its potent action against rapidly dividing cells, when used with careful monitoring, supports cancer management and improves survival outcomes under strict medical supervision.